Clinical Trial Update: Study of Imatinib and Peginterferon α-2b in Gastrointestinal Stromal Tumor (GIST) Patients [Phase 2]

View source ↗

Summary

Phase 2 study evaluating imatinib in combination with peginterferon alfa-2b in patients with gastrointestinal stromal tumors. The trial was terminated and resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer
• Gastrointestinal Stromal Tumor

Drugs mentioned

• Imatinib (imatinib)
• Peginterferon alfa-2b (Peginterferon alfa-2b)

Snippet

Sponsor: University of Utah | Conditions: Gastrointestinal Stromal Tumors, Cancer Brain | Phase 2 | Status: TERMINATED | Results posted: 2012-11-21